Dipeptidyl peptidase IV inhibitors as novel regulators of vascular disease

Dipeptidyl peptidase IV (DPP-IV) has been revealed as an adipokine with potential relevance in cardiovascular disease (CVD), while clinically used DPP-IV inhibitors have demonstrated beneficial cardiovascular effects in several experimental studies. Perivascular adipose tissue (PVAT) is a unique adi...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Akoumianakis, I, Antoniades, C
Format: Journal article
Sprache:English
Veröffentlicht: Elsevier 2017